NCT00244959View on ClinicalTrials.gov

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

November 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

anastrozole

1 mg orally daily for 12 months

PROCEDURE

adjuvant therapy

treatment received after breast cancer surgery

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00244959 - Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer | Biotech Hunter | Biotech Hunter